Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$4.0 - $5.49 $80,204 - $110,079
20,051 New
20,051 $107,000
Q2 2023

Aug 11, 2023

BUY
$4.19 - $6.16 $9,490 - $13,952
2,265 Added 12.23%
20,779 $114,000
Q1 2023

May 16, 2023

BUY
$2.45 - $4.22 $10,939 - $18,842
4,465 Added 31.78%
18,514 $77,000
Q4 2022

Feb 14, 2023

BUY
$2.12 - $2.86 $29,783 - $40,180
14,049 New
14,049 $38,000
Q2 2022

Aug 15, 2022

BUY
$3.28 - $6.42 $75,403 - $147,589
22,989 New
22,989 $83,000
Q1 2022

May 16, 2022

SELL
$5.16 - $7.14 $118,994 - $164,655
-23,061 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$6.37 - $8.18 $8,631 - $11,083
-1,355 Reduced 5.55%
23,061 $163,000
Q3 2021

Nov 15, 2021

BUY
$6.98 - $8.47 $6,707 - $8,139
961 Added 4.1%
24,416 $170,000
Q2 2021

Aug 11, 2021

BUY
$5.44 - $8.4 $41,490 - $64,066
7,627 Added 48.19%
23,455 $195,000
Q1 2021

May 17, 2021

BUY
$3.91 - $6.99 $61,887 - $110,637
15,828 New
15,828 $86,000
Q3 2020

Nov 16, 2020

SELL
$2.75 - $4.2 $181,500 - $277,200
-66,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$2.12 - $3.14 $93,388 - $138,320
44,051 Added 200.7%
66,000 $205,000
Q1 2020

May 15, 2020

BUY
$1.42 - $3.29 $31,167 - $72,212
21,949 New
21,949 $49,000
Q3 2019

Nov 14, 2019

SELL
$1.59 - $3.47 $26,732 - $58,341
-16,813 Closed
0 $0
Q2 2019

Aug 16, 2019

BUY
$1.93 - $4.59 $1,891 - $4,498
980 Added 6.19%
16,813 $34,000
Q2 2019

Aug 14, 2019

BUY
$1.93 - $4.59 $30,557 - $72,673
15,833 New
15,833 $32,000
Q2 2018

Aug 14, 2018

SELL
$4.2 - $5.95 $321,762 - $455,829
-76,610 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$3.3 - $5.15 $252,813 - $394,541
76,610 New
76,610 $383,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.